![]() ZOAMBXDOGPRZLP-UHFFFAOYSA-N indole-3-acetamide Chemical compound C1=CC=C2C(CC(=O)N)=CNC2=C1 ZOAMBXDOGPRZLP-UHFFFAOYSA-N 0.000 description 144.230000011869 shoot development Effects 0.000 claims description 6.235000013399 edible fruits Nutrition 0.000 claims description 6.238000005859 coupling reaction Methods 0.000 claims description 6.238000010168 coupling process Methods 0.000 claims description 6.VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 10.IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 claims description 12.239000003448 gibberellin Substances 0.000 claims description 12.102000018700 F-Box Proteins Human genes 0.000 claims description 32.ZNJFBWYDHIGLCU-HWKXXFMVSA-N Jasmonic acid Chemical compound ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 claims description 34.102000037240 fusion proteins Human genes 0.000 claims description 46.108020001507 fusion proteins Proteins 0.000 claims description 46.230000014509 gene expression Effects 0.000 claims description 122.YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 132.SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 364.101700006494 nucA Proteins 0.000 claims abstract description 12.108010082319 CRISPR-Associated Protein 9 Proteins 0.000 claims abstract description 12.108010077850 Nuclear Localization Signals Proteins 0.000 claims abstract description 38.238000010354 CRISPR gene editing Methods 0.000 claims abstract description 38.230000033228 biological regulation Effects 0.000 claims abstract description 64.230000019491 signal transduction Effects 0.000 claims abstract description 78.230000002103 transcriptional Effects 0.000 claims abstract description 90.229920000033 CRISPR Polymers 0.000 title claims abstract description 44.239000005556 hormone Substances 0.000 title claims abstract description 68.229940088597 Hormone Drugs 0.000 title claims abstract description 68.102000003995 transcription factors Human genes 0.000 title claims abstract description 100.108090000464 transcription factors Proteins 0.000 title claims abstract description 100.Publication of US20170369892A1 publication Critical patent/US20170369892A1/en Status Abandoned legal-status Critical Current Links Assignors: KHAKHAR, ARJUN, KLAVINS, ERIC, NEMHAUSER, JENNIFER L. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201662353403P external-priority Application filed by University of Washington filed Critical University of Washington Priority to US15/630,817 priority Critical patent/US20170369892A1/en Assigned to UNIVERSITY OF WASHINGTON reassignment UNIVERSITY OF WASHINGTON ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee University of Washington Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Nemhauser Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US15/630,817 Inventor Eric KLAVINS Arjun Khakhar Jennifer L. Google Patents US20170369892A1 - Hormone degradable crispr-based transcription factors US20170369892A1 - Hormone degradable crispr-based transcription factors
0 Comments
Leave a Reply. |